711 related articles for article (PubMed ID: 8096133)
1. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
2. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
4. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
5. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
6. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective action of roxatidine acetate HCl.
Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
[TBL] [Abstract][Full Text] [Related]
8. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
9. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
13. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
15. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel xanthine derivative on experimental ulcers in rats.
Tanaka T; Morioka Y; Gebert U
Arzneimittelforschung; 1993 May; 43(5):558-62. PubMed ID: 8329000
[TBL] [Abstract][Full Text] [Related]
17. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
18. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
20. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
